Product Images Levetiracetam

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Levetiracetam NDC 0143-9574 by Hikma Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

chemical structure - levetiracetam injection novaplus 1

NDC 0143-9574-25 Rx ONLY Levetiracetam Injection FOR IV USE ONLY 500 mg/5 mL (100 mg/mL) MUST BE DILUTED PRIOR TO ADMINISTRATION 25 x 5 mL Single Dose Vials Each 5 mL vial contains 500 mg levetiracetam, 8.2 mg sodium acetate trihydrate, 45 mg sodium chloride, glacial acetic acid for pH adjustment to 6. USUAL DOSAGE: See package insert. DISCARD UNUSED PORTION. RETAIN IN CARTON UNTIL TIME OF USE. Store at 25ºC (77ºF); excursions permitted to 15º to 30ºC (59º to 86ºF) [See USP Controlled Room Temperature]. - levetiracetam injection novaplus 10

This text appears to contain product identification information including a GTIN (Global Trade Item Number), SN (Serial Number), EXP (Expiration Date), and LOT (Lot Number). The specific values for each of these identification fields are not provided.*

Figure 1: Responder Rate (≥50% Reduction from Baseline) in Study 1 - levetiracetam injection novaplus 2

The text is not readable.*

Figure 2: Responder Rate (≥50% Reduction from Baseline) in Study 2: Period A - levetiracetam injection novaplus 3

Figure 3: Responder Rate (≥50% Reduction from Baseline) in Study 3 - levetiracetam injection novaplus 4

Figure 4: Responder Rate (≥ 50% Reduction from Baseline) in Study 4 - levetiracetam injection novaplus 5

This appears to be a table or chart displaying the percentages of individuals in two different groups (placebo and levetiracetam) for some variable or outcome measure. Without additional information or context, it is not possible to determine the specific variable or outcome being measured.*

Figure 5: Responder Rate for All Patients Ages 1 Month to < 4 Years (≥ 50% Reduction from Baseline) in Study 5 - levetiracetam injection novaplus 6

This appears to be a table or graph showing percentages attributed to "Placebo" and "Levetiracetam" with corresponding sample sizes. However, there is not enough context to determine what these percentages and sample sizes represent.*

Figure 6: Responder Rate (≥50% Reduction from Baseline) in PGTC Seizure Frequency per Week in Study 7 - levetiracetam injection novaplus 7

NDC 0143-9574-01 Rx ONLY Levetiracetam Injection FOR IV USE ONLY 500 mg/5 mL (100 mg/mL) MUST BE DILUTED PRIOR TO ADMINISTRATION 5 mL Single Dose Vial USUAL DOSAGE: See package insert. DISCARD UNUSED PORTION. RETAIN IN CARTON UNTIL TIME OF USE. Store at 25ºC (77ºF); excursions permitted to 15º to 30ºC (59º to 86ºF) [See USP Controlled Room Tem- perature]. - levetiracetam injection novaplus 8

This is a description of Levetiracetam Injection, which is used for IV administration. The injection comes in a 5 ml single-dose vial with a strength of 500 mg per 5 ml. It is recommended to dilute the injection before administration. The usual dosage should be followed, and any unused portion should be discarded. The injection should be stored at a controlled room temperature of 25°C (77°F) but can also be stored between 15°C to 30°C (59°F to 86°F), as permitted by USP. The text includes the manufacturer's name and address, but no other useful information is visible.*

NDC 0143-9574-10 Rx ONLY Levetiracetam Injection FOR IV USE ONLY 500 mg/5 mL (100 mg/mL) MUST BE DILUTED PRIOR TO ADMINISTRATION 10 x 5 mL Single Dose Vials Each 5 mL vial contains 500 mg levetiracetam, 8.2 mg sodium acetate trihydrate, 45 mg sodium chloride, glacial acetic acid for pH adjustment to 6. USUAL DOSAGE: See package insert. DISCARD UNUSED PORTION. RETAIN IN CARTON UNTIL TIME OF USE. Store at 25ºC (77ºF); excursions permitted to 15º to 30ºC (59º to 86ºF) [See USP Controlled Room Temperature]. - levetiracetam injection novaplus 9

Levetiracetam Injection is a prescription medication that comes in a 5 mL single-dose vial. The vial contains 500 mg of the active ingredient levetiracetam per 5 mL, which must be diluted before administering. Each vial also contains 8.2 mg of sodium acetate trihydrate, 45 mg of sodium chloride, and glacial acetic acid. The usual dosage is included in the package insert. Unused portions should be discarded, and the medication should be stored at 25°C (77°F) with permissible excursions from 10 to 30°C (59° to 86°F) controlled room temperature. The product is distributed by Hikma in NJ, USA, under the brand name Novaplus™.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.